Cognition Therapeutics Inc (NASDAQ: CGTX) is -82.46% lower on its value in year-to-date trading and has touched a low of $0.22 and a high of $2.54 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CGTX stock was last observed hovering at around $0.30 in the last trading session, with the day’s gains setting it 0.84%.
Currently trading at $1.14M, the stock is 10.59% and -2.93% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.99 million and changing 991332% at the moment leaves the stock -32.36% off its SMA200. CGTX registered -53.73% loss for a year compared to 6-month loss of -48.50%. The firm has a 50-day simple moving average (SMA 50) of $0.33432 and a 200-day simple moving average (SMA200) of $0.47975.
The stock witnessed a 25.53% gain in the last 1 month and extending the period to 3 months gives it a -26.52%, and is 15.89% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.93% over the week and 12.12% over the month.
Cognition Therapeutics Inc (CGTX) has around 28 employees, a market worth around $20.12M and $0.00M in sales. Distance from 52-week low is 45.97% and -87.20% from its 52-week high. The company has generated returns on investments over the last 12 months (-265.34%).
The EPS is expected to grow by 52.62% this year
53.0 institutions hold shares in Cognition Therapeutics Inc (CGTX), with institutional investors hold 18.94% of the company’s shares. The shares outstanding are 61.97M, and float is at 50.00M with Short Float at 3.08%. Institutions hold 18.79% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 1.15 million shares valued at $1.9 million. The investor’s holdings represent 2.8644 of the CGTX Shares outstanding. As of 2024-06-30, the second largest holder is AWM INVESTMENT COMPANY, INC. with 0.65 million shares valued at $1.08 million to account for 1.6224 of the shares outstanding. The other top investors are ALYESKA INVESTMENT GROUP, L.P. which holds 0.5 million shares representing 1.248 and valued at over $0.83 million, while TIMELO INVESTMENT MANAGEMENT INC. holds 0.9021 of the shares totaling 0.36 million with a market value of $0.6 million.
Cognition Therapeutics Inc (CGTX) Insider Activity
The most recent transaction is an insider purchase by Ricciardi Lisa, the company’s CEO & President. SEC filings show that Ricciardi Lisa bought 38,851 shares of the company’s common stock on Jan 31 ’25 at a price of $0.77 per share for a total of $30001.0. Following the purchase, the insider now owns 38851.0 shares.
